Panayiotis S. Savvides, MD, discusses the utility of immunotherapy in lung cancer.
Panayiotis S. Savvides, MD, a medical oncologist at Mayo Clinic Arizona, discusses the utility of immunotherapy in lung cancer.
Documenting the efficacy of immunotherapy in lung cancer has revolutionized what patients have been offered over the past few years, says Savvides. The options that are avaliable to patients have significantly improved with these advances, adds Savvides. Interestingly, the safety profile of immunotherapies completely differs from that of cytotoxic chemotherapy regimens that the field had been using. Immunotherapy appears to have a more favorable safety profile, concludes Savvides.